Lv11
70 积分 2022-11-11 加入
An updated patent review of BRD4 degraders
3天前
已完结
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours
1年前
已完结
Structure Based Design of PARP Inhibitors
1年前
已完结
Impact of Co-chaperones and Posttranslational Modifications Toward Hsp90 Drug Sensitivity
2年前
已完结
Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders
2年前
已完结
The Right Tool for the Job: An Overview of Hsp90 Inhibitors
2年前
已完结
The Therapeutic Potential of Targeting Hsp90-Cdc37 Interactions in Several Diseases
2年前
已完结
The Bacterial Hsp90 Chaperone: Cellular Functions and Mechanism of Action
2年前
已完结
皖公网安备34019202002308
